Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
about
Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson's disease without cognitJNP special issue on Parkinson's disease and cognition.The limbic-reticular coupling theory of memory processing in the brain and its greater compatibility over other theories.
P2860
Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
@en
Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
@nl
type
label
Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
@en
Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
@nl
prefLabel
Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
@en
Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
@nl
P2093
P2860
P356
P1476
Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
@en
P2093
Andrew R Mayes
Nicola M J Edelstyn
Simon J Ellis
Thomas A Shepherd
P2860
P304
P356
10.1111/JNP.12025
P577
2013-07-02T00:00:00Z